AMI ANEMIA MANAGEMENT INSTITUTE, created in 2004 (United States), from 142 sister brands and 17477 competing brands. AMI ANEMIA MANAGEMENT INSTITUTE is owned by Amgen, listed on the stock exchange of New York AMI ANEMIA MANAGEMENT INSTITUTE belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
Amgen
(AMI ANEMIA MANAGEMENT INSTITUTE)
over 5 years*
USD 421.35